0 CHECKOUT

Oman Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3511236
  • December 2015
  • Region: Oman
  • 73 pages
  • Business Monitor International
1 of 4

Oman's pharmaceuticals and healthcare market will remain an attractive investment proposition for international players. Despite the public sector holding the greatest market share, the private sector will play a pivotal role in healthcare expansion over the long term. The rising cost of medical services will be kept in check to an extent by the downward pressure on drug prices - mainly driven by the Gulf Cooperation Council's medicine price unification process. Over the long term, Oman's population will benefit from more affordable healthcare services as price unification becomes more standardised across the Gulf States.

Headline Expenditure Projections
- Pharmaceuticals: OMR205mn (USD532mn) in 2014 to OMR219mn (USD568mn) in 2015; 6.8% in local currency and US dollar terms. Forecast in line with Q415.

- Healthcare: OMR885mn (USD2.30bn) in 2014 to OMR961mn (USD2.50bn) in 2015; +8.5% in local currency and US dollar terms. Forecast revised upwards from Q415.

Note: Product cover images may vary from those shown
2 of 4

Table: Headline Pharmaceuticals & Healthcare Forecasts (Oman 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2013-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2013-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2013-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2013-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2013-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2013-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2013-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2013-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Oman 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Oman 2013-2019)

Industry Risk/Reward Index

Middle East and Africa Risk/Reward Index - Q1 2016

Oman Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing Regime

Regional Harmonisation

Market Overview

Healthcare Sector
Table: Healthcare Resources (Oman 2009-2014)
Table: Healthcare Personnel (Oman 2009-2014)
Table: Healthcare Activity (Oman 2009-2014)

Research & Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Multinational Market Activity

Generic Drugmakers

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

National Pharmaceutical Industries

Zynova/Oman Pharmaceutical Products Company

Demographic Forecast
Table: Population Headline Indicators (Oman 1990-2025)
Table: Key Population Ratios (Oman 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Oman 1990-2025)
Table: Population By Age Group (Oman 1990-2025)
Table: Population By Age Group % (Oman 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

National Pharmaceutical Industries
Zynova/Oman Pharmaceutical Products Company

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.